When a federal judge blocks an administration from acting on a major public-policy dispute, the country is entitled to ask whether the court is applying the law or simply imposing a preferred outcome from the bench. The latest example comes out of Oregon, where U.S. District Judge Mustafa Kasubhai, a Biden-era appointee, ruled against the Trump administration’s effort to restrict federal support for transgender treatments for minors. According to Reuters, Kasubhai said Health Secretary Robert F. Kennedy Jr. exceeded his authority when HHS issued a December declaration stating that certain gender-transition interventions for minors were not safe and effective and warning providers that they could face exclusion from federal health programs.
The legal issue in the case is one thing. The broader institutional problem is another. Judges are increasingly stepping into the middle of politically charged national fights and freezing executive action before voters can even see whether the elected branch can carry out its program. That pattern turns district courts into de facto veto points over national policy. It also feeds the public perception that some judges are less interested in judicial restraint than in blocking the policies they dislike.
What The Judge Actually Did
Reuters reported that the ruling came in a lawsuit filed by Democratic-led states challenging HHS’s declaration, which had warned that providers offering puberty blockers, hormone therapy, and surgeries to minors for gender dysphoria could risk participation in Medicare, Medicaid, and the Children’s Health Insurance Program. Reuters said Kasubhai concluded that the declaration likely exceeded HHS’s legal authority and rejected the government’s effort to dismiss the case. See Reuters’ report here.
The Associated Press similarly reported that the judge found the government overreached and bypassed required administrative procedures when it issued the declaration. AP said the ruling grants preliminary relief to providers and keeps the federal government from punishing them under the declaration while the case proceeds. See AP’s coverage here.
That means the court did not merely offer a technical procedural reminder. It effectively stopped a major piece of the administration’s policy posture on transgender treatments for minors before the elected branch could fully implement it.
This Is Part Of A Larger Problem
The public keeps getting told these are neutral procedural rulings. Sometimes they are. But the cumulative effect is unmistakable. District judges across the country have become central players in national policymaking, especially on immigration, healthcare, and culture-war issues. Reuters reported in early 2025 that another federal judge blocked Trump’s order curbing federal support for gender-transition treatments for minors in several Democratic-led states. See Reuters’ February 2025 report. Reuters also reported on a later order further extending that block. See Reuters’ March 2025 report.
When this keeps happening, voters start to see the obvious. Executive authority exists on paper, but in practice it is often suspended by one judge sitting in one courtroom. That is not healthy for a constitutional system that is supposed to give substantial policy-making discretion to elected officials within the bounds of the law.
There Is A Serious Public Interest In Restricting These Treatments For Minors
The media often frames this debate as if the only serious position is to preserve access to these treatments and view any restriction as cruelty. That is not the whole picture. HHS’s declaration was based in part on the administration’s position that these interventions for minors do not meet adequate standards of safety and effectiveness. AP reported that the declaration called puberty blockers, hormone therapy, and surgery unsafe and ineffective for young people experiencing gender dysphoria. See AP.
There is plainly a live national dispute over whether minors should be placed on puberty blockers, cross-sex hormones, or surgical pathways in response to gender dysphoria. That dispute is not fringe. It is legislative, medical, legal, and cultural. In a system of self-government, the elected branches should have room to respond to that dispute through policy, especially when federal funding and program participation are involved.
The Real Question Is Who Decides
Reasonable people can debate the best policy on these treatments. The larger constitutional question is who gets to decide. Should it be elected officials, answerable to voters, using the tools of the executive branch to shape federal program rules and healthcare guidance. Or should it be one district judge deciding that the administration moved too aggressively and must stop.
That question matters because the ruling does not merely affect Oregon. Reuters reported that the case was brought by multiple Democratic-led states, and the practical effect is to shield providers more broadly while the litigation continues. See Reuters. That is exactly how district-court power expands from case-specific review into national policy control.
Activist Judging Often Hides Behind Procedure
To be clear, not every ruling against an administration is activist. Courts have a duty to police statutory limits. But it is also true that activism now often comes wrapped in procedural language. A judge does not have to announce a political motive to achieve a political result. He only has to say the agency moved too fast, skipped a step, used the wrong mechanism, or failed to satisfy a technical requirement. The practical effect is the same. The administration’s policy is frozen, sometimes for months, sometimes for years.
That is why rulings like this generate so much public anger. The public sees a substantive policy blocked and is told to pretend the court is only making a narrow procedural point. But when the narrow procedural point always seems to cut in the same ideological direction, people draw their own conclusions.
How Activist Judges Should Be Reined In
- Appellate courts should move faster. Major national-policy injunctions should not linger indefinitely while administrations are blocked from acting.
- The Supreme Court should narrow universal and quasi-national injunction practices. One district judge should not function as a national policy governor.
- Congress should clarify executive authority where possible. Ambiguity invites litigation and encourages lower courts to insert themselves deeper into policy disputes.
- The public should stop accepting the fiction that every politically consequential ruling is purely technical. Judicial power is real power, and it should be scrutinized like any other power.
Conclusion
The Oregon ruling against Trump HHS is about more than one declaration and more than one policy fight over transgender treatments for minors. It is another example of the growing tendency of federal judges to halt major executive actions at the trial-court level, often by framing broad policy intervention as narrow legal housekeeping. According to Reuters and AP, the judge concluded HHS overstepped. Fine. The appeals process exists for exactly that reason.
But the broader lesson remains. Activist judges have amassed too much practical power over national policy, and district-court intervention is increasingly being used to stop elected administrations from governing. If the country wants more accountability and less rule by injunction, that trend needs to be reined in.
Leave a Reply